{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:56:01Z","timestamp":1777496161985,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH112485"],"award-info":[{"award-number":["T32MH112485"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jad.2023.08.135","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T11:18:21Z","timestamp":1693567101000},"page":"374-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Residual symptoms following electroconvulsive therapy: A retrospective cohort study"],"prefix":"10.1016","volume":"341","author":[{"given":"Kamber L.","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Thomas H.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Seiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Luccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.08.135_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cpr.2018.07.005","article-title":"Risk factors for relapse and recurrence of depression in adults and how they operate: a four-phase systematic review and meta-synthesis","volume":"64","author":"Buckman","year":"2018","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2023.08.135_bb0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S0033291710001911","article-title":"Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study","volume":"41","author":"Conradi","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2023.08.135_bb0015","series-title":"Depression, Primer on","article-title":"Pharmacological strategies for targeting residual symptoms in depression","author":"Fava","year":"2020"},{"key":"10.1016\/j.jad.2023.08.135_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/104012371702900107","article-title":"Differentiating residual symptoms of depression from adverse events among patients initiating treatment with an antidepressant","volume":"29","author":"Freeman","year":"2017","journal-title":"Ann. Clin. Psychiatry Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2023.08.135_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jad.2021.11.002","article-title":"Individual response to electroconvulsive therapy is not correlated between multiple treatment courses","volume":"298","author":"Hart","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.08.135_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/764649","article-title":"Short-term effects of electroconvulsive therapy on subjective and actigraphy-assessed sleep parameters in severely depressed inpatients","volume":"2015","author":"Hoogerhoud","year":"2015","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.jad.2023.08.135_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/da.20768","article-title":"Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse","volume":"28","author":"Iovieno","year":"2011","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2023.08.135_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpsychires.2022.07.056","article-title":"Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?","volume":"154","author":"Lambrichts","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.08.135_bb0045","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.brs.2020.08.009","article-title":"Charge required to induce a seizure during initial dose titration using right unilateral brief pulse electroconvulsive therapy","volume":"13","author":"Luccarelli","year":"2020","journal-title":"Brain Stimulat."},{"key":"10.1016\/j.jad.2023.08.135_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/YCT.0000000000000714","article-title":"Total charge required to induce a seizure in a retrospective cohort of patients undergoing dose titration of right unilateral ultrabrief pulse electroconvulsive therapy","volume":"37","author":"Luccarelli","year":"2021","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2023.08.135_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00406-020-01202-2","article-title":"Rate of continuing acute course treatment using right unilateral ultrabrief pulse electroconvulsive therapy at a large academic medical center","volume":"271","author":"Luccarelli","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2023.08.135_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCT.0000000000000768","article-title":"Duration of treatment in electroconvulsive therapy among patients beginning with acute course right unilateral brief pulse stimuli","volume":"37","author":"Luccarelli","year":"2021","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2023.08.135_bb0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.brs.2022.08.011","article-title":"Electroconvulsive therapy is associated with a reduction in self-reported suicidal ideation in adolescents","volume":"15","author":"Luccarelli","year":"2022","journal-title":"Brain Stimulat."},{"key":"10.1016\/j.jad.2023.08.135_bb0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JCP.0b013e31820ebd2c","article-title":"Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication","volume":"31","author":"McClintock","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.08.135_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2023.08.135_bb0080","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2019"},{"key":"10.1016\/j.jad.2023.08.135_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.08.135_bb0090","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","article-title":"Report by the ACNP task force on response and remission in major depressive disorder","volume":"31","author":"Rush","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2023.08.135_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2021.12.115","article-title":"Residual symptoms after achieving remission with repetitive transcranial magnetic stimulation in depression","volume":"301","author":"Sakurai","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.08.135_bb0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jad.2022.08.075","article-title":"What does \u201cstaying well\u201d after depression mean? Chronic low grade symptomatology after treatment for depression is common","volume":"317","author":"Strege","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.08.135_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.746678","article-title":"A systematic review and individual patient data network analysis of the residual symptom structure following cognitive-behavioral therapy and escitalopram, mirtazapine and venlafaxine for depression","volume":"13","author":"Whiston","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2023.08.135_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.12084su1c.02","article-title":"Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances","volume":"74","author":"Zajecka","year":"2013","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723011217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723011217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:15:55Z","timestamp":1759032955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723011217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"alternative-id":["S0165032723011217"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.08.135","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual symptoms following electroconvulsive therapy: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.08.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}